Lack of observed impact of history or concomitant treatment of seasonal allergies or rhinitis on repeated doses of diazepam nasal spray administered per seizure episode in a day, safety, and tolerability: Interim results from a phase 3, open-label, 12-month repeat-dose safety study

Publication date: May 2021Source: Epilepsy & Behavior, Volume 118Author(s): Blanca Vazquez, James Wheless, Jay Desai, Adrian L. Rabinowicz, Enrique Carrazana
Source: Epilepsy and Behavior - Category: Neurology Source Type: research